Abstract:Chronic kidney disease (CKD) can be diagnosed by chronic deterioration in kidney function associated with renal parenchymal damage and may progress to end-stage renal disease (ESRD), [ 1 ] which has become a major public health concern. More than 800 million individuals are affected by CKD in 2017, and CKD was predicted to be the fifth leading cause of years of life lost. [ 2 , 3 ] CKD patients had higher mortality rates, [ 4 ] and CKD represents a major public health issue in Taiwan. Wen et al revealed that more than 10% of the Taiwanese population may be affected by CKD. [ 5 ] Comorbidities, such as cardiovascular disease (CVD) and congestive heart failure, not only exacerbate CKD progression but also impact the quality of life and mortality in CKD patients. [ 1 ] Common treatment options for ESRD patients include kidney transplantation and dialysis. [ 6 ] Despite advances in dialysis technology and cardiovascular therapies, cardiovascular-related mortality due to cardiac arrhythmias remains the largest cause of death among patients undergoing general dialysis. In ESRD patients treated with hemodialysis, the incidence of congestive heart failure had increased to 77.3% in 2021. [ 7 ] Given the high morbidity and mortality of these intertwined diseases, the use of hospice palliative care for patients with advanced CKD and CVD is critical to ensure that patients could make informed medical decisions and receive optimal treatment for their needs. Similar to CVD and congestive heart failure, the progression from pre-ESRD to ESRD is highly variable and can follow an unpredictable trajectory. [ 8 , 9 ] Consequently, it is important to understand the progression trajectory to properly initiate and integrate palliative care services, such as the management of patient symptoms and discussion of renal replacement therapy options, including dialysis and non-dialysis management for advanced CKD patients. [ 10 , 11 ] There are already numerous studies on the epidemiology and short-term survival of ESRD patients, [ 12–14 ] but the research on the long-term survival of non-cancer patients with advanced CKD is scarce. Machine learning (ML) has been applied successfully to different chronic diseases, such as chronic liver diseases, CVD, chronic obstructive pulmonary disease, and metabolic syndrome. [ 15–23 ] Furthermore, several studies in the past 2 years have utilized time-series ML techniques to predict the COVID-19 pandemic trend. [ 20 ] Previous studies also used unsupervised learning and network visualization of big data for chronic disease diagnoses. [ 24 ] Machine learning techniques were used in several research about renal problems such as CKD early detection in the EHR database or prediction for acute kidney injury. Several studies have been conducted on the use of artificial intelligence (AI) in ESRD and CKD. [ 20 , 25–29 ] However, these studies mostly focused on CKD prevention or identification. [ 21 , 30–33 ] For mortality prediction in ESRD patients, most studies have focused on populations with only kidney transplant therapy or hemodialysis. [ 34–36 ] Therefore, this study intends to construct a mortality prediction model with AI for pre-ESRD and ESRD patients.

#4784 IDENTIFICATION OF FACTORS ASSOCIATED WITH DEATH IN DIALYSIS PATIENTS USING A MACHINE LEARNING-BASED PREDICTIVE MODEL

Machine Learning for the Prediction of First-Year Mortality in Incident Hemodialysis Patients

Prognostic Machine Learning Models for First-Year Mortality in Incident Hemodialysis Patients: Development and Validation Study.

Early Mortality and Risk Analysis in Adult Patients with Maintenance Hemodialysis

Predicting early mortality in hemodialysis patients: a deep learning approach using a nationwide prospective cohort in South Korea

Machine Learning for Identification of Short-Term All-Cause and Cardiovascular Deaths among Patients Undergoing Peritoneal Dialysis Patients

Interpretable machine learning models for the prediction of all‐cause mortality and time to death in hemodialysis patients

Data-driven, two-stage machine learning algorithm-based prediction scheme for assessing 1-year and 3-year mortality risk in chronic hemodialysis patients

Prediction of mortality in hemodialysis patients based on autoencoders

Specific patterns and potential risk factors to predict 3-year risk of death among non-cancer patients with advanced chronic kidney disease by machine learning

Machine learning algorithm to predict the in-hospital mortality in critically ill patients with chronic kidney disease

Machine learning algorithms for the prediction of adverse prognosis in patients undergoing peritoneal dialysis

Modifiable Risk Factors Are Important Predictors of COVID-19-Related Mortality in Patients on Hemodialysis

Analysis of Death Causes and Predictive Factors in Patients Receiving Maintenance Hemodialysis and Peritoneal Dialysis

Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients

MO890: Modifiable and Non-Modifiable Factors Associated With Increased COVID-19 Related Mortality Among Dialysis Patients

Initiation Condition of Hemodialysis is Independently Associated with All-Cause Mortality in Maintenance Hemodialysis Patients: A Retrospective Study.

Designing an Implementable Clinical Prediction Model for Near-Term Mortality and Long-Term Survival in Patients on Maintenance Hemodialysis

Analysis of Factors Associated with Death in Maintenance Hemodialysis Patients: A Multicenter Study in China

A maintenance hemodialysis mortality prediction model based on anomaly detection using longitudinal hemodialysis data

Development of a Prediction Model to Estimate the 5-Year Risk of Cardiovascular Events and All-Cause Mortality in Haemodialysis Patients: a Retrospective Study